The third-party study is definitely helping IMO, though that particular study did also have a statement in the conclusion that they could not rule out that the improvements were not related to the PT alone. This was FDA's main gripe, but given that all these patients had been doing PT before and were no longer improving, I find it hard to imagine PT (or placebo effect) was the sole reason for the dramatic improvements.
With the existing Canadian clinics alone, by their own estimates, they should achieve annual revenues of $7MM. If traction continues and they get more clinics and actual results yield the same outcomes as the studies, then an FDA approval would be huge. But Canada alone can easily make this a profitable business. Time will tell .. so far not much press out of the Canadian clinics...
News 
Market Data 
Discover 
